Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;23(1):e16.
doi: 10.4142/jvs.21188.

Xylazole inhibits NO-cGMP pathway in fetal rat nerve cells

Affiliations

Xylazole inhibits NO-cGMP pathway in fetal rat nerve cells

Xinyu Wang et al. J Vet Sci. 2022 Jan.

Abstract

Background: Xylazole (Xyl) is a veterinary anesthetic that is structurally and functionally similar to xylazine. However, the effects of Xyl in vitro remain unknown.

Objectives: This study aimed to investigate the anesthetic mechanism of Xyl using fetal rat nerve cells treated with Xyl.

Methods: Fetal rat nerve cells cultured for seven days were treated with 10, 20, 30, and 40 μg/ mL Xyl for 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min. Variations of amino acid neurotransmitters (AANTs), Nitric oxide-Cyclic GMP (NO-cGMP) signaling pathway, and ATPase were evaluated.

Results: Xyl decreased the levels of cGMP and NO in nerve cells. Furthermore, Xyl affected the AANT content and Na+-K+-ATPase and Ca2+-Mg2+-ATPase activity in nerve cells. These findings suggested that Xyl inhibited the NO-cGMP signaling pathway in nerve cells in vitro.

Conclusions: This study provided new evidence that the anesthetic and analgesic effects of Xyl are related to the inhibition of the NO-cGMP signaling pathway.

Keywords: Xylazole; anesthesia; cyclic GMP; gamma-aminobutyric acid; glutamic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Observation of fetal rat cerebral cortex nerve cells cultured in vitro. Observation of fetal rat cerebral cortex nerve cells cultured in vitro for 3 h (A), 3 day (B), 7 day (C) and immunofluorescence staining under the same field of view on the 7th day (D).
Fig. 2
Fig. 2. Effects of different concentrations of Xyl on nerve cell viability. Values were expressed as mean ± SEM.
Xyl, xylazole.
Fig. 3
Fig. 3. Effects of Xyl on the NO-cGMP signaling pathway. (A-E) The NO content; (F-J) The cGMP content. Values were expressed as mean ± SEM.
Xyl, xylazole. *p < 0.05, **p < 0.01 vs. control group; # p < 0.05, ##p < 0.01 vs. xylazine group.
Fig. 4
Fig. 4. Effects of Xyl on the AANTs. (A-E) The GABA content; (F-J) The Glu content; (K-O) The Asp content. Values were expressed as mean ± SEM.
Xyl, xylazole; GABA, γ-aminobutyric acid; AANT, amino acid neurotransmitter. *p < 0.05, **p < 0.01 vs. control group.
Fig. 5
Fig. 5. Effects of Xyl on the ATPase. (A-E) The Na+-K+-ATPase activity; (F-J) The Ca2+-Mg2+-ATPase activity. Values were expressed as mean ± SEM.
Xyl, xylazole. *p < 0.05, **p < 0.01 vs. control group.

References

    1. Schmitt H, Le Douarec JC, Petillot N. Antagonism of the antinociceptive action of xylazine, an alpha-sympathomimetic agent, by adrenoceptor and cholinoceptor blocking agents. Neuropharmacology. 1974;13(5):295–303. - PubMed
    1. Tao R, Hjorth S. Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo . Naunyn Schmiedebergs Arch Pharmacol. 1992;345(2):137–143. - PubMed
    1. Rong YF, Hsu WH, Hembrough FB. Effects of xylazole on heart rate and blood pressure in conscious dogs. Zhongguo Yao Li Xue Bao. 1989;10(5):410–414. - PubMed
    1. Hsu WH, Rong YF, Hembrough FB. The effects of jingsongling, a xylazine analog, on mean arterial blood pressure and heart rate in dogs--influences of yohimbine, tolazoline, prazosin, and atropine. J Vet Pharmacol Ther. 1989;12(3):283–288. - PubMed
    1. Xiong HJ. Veterinary Anaesthesia. Beijing: China Agricultural Press; 2004.